Clinical Research of Generic Drugs and Innovative Drugs
In 2015, the Chinese Food and Drug Administration launched the "722" inspection, and the quality of a large number of clinical data was questioned. The relevant laws and regulations for registration and clinical trials are further in line with the current ICH-GCP standards, and more emphasis is placed on the clinical value of patient-centered drug development and research and development projects.